PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer

CRANBURY, N.J., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, today announced the appointment of Dr. Salim... Biopharmaceuticals, Oncology, Personnel PMV Pharma, p53
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news